LCCC 1025: Phase II study of everolimus, trastuzumab, and vinorelbine for HER2+ breast cancer brain metastases (BCBM).Carey K. Anders, Lisa A. Carey, Amanda Elyse Day Van Swearingen et al.|Journal of Clinical Oncology|2017Cited by 4